Zhejiang Huakang Pharmaceutical Co., Ltd.

SHSE:605077 Voorraadrapport

Marktkapitalisatie: CN¥4.5b

Zhejiang Huakang Pharmaceutical Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Deshui Chen

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO15.9%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Zhejiang Huakang Pharmaceutical's (SHSE:605077) Anemic Earnings Might Be Worse Than You Think

Nov 02
Zhejiang Huakang Pharmaceutical's (SHSE:605077) Anemic Earnings Might Be Worse Than You Think

Zhejiang Huakang Pharmaceutical Co., Ltd.'s (SHSE:605077) Earnings Are Not Doing Enough For Some Investors

Oct 14
Zhejiang Huakang Pharmaceutical Co., Ltd.'s (SHSE:605077) Earnings Are Not Doing Enough For Some Investors

Zhejiang Huakang Pharmaceutical (SHSE:605077) Will Want To Turn Around Its Return Trends

Sep 26
Zhejiang Huakang Pharmaceutical (SHSE:605077) Will Want To Turn Around Its Return Trends

Improved Earnings Required Before Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Shares Find Their Feet

Jul 02
Improved Earnings Required Before Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Shares Find Their Feet

Zhejiang Huakang Pharmaceutical (SHSE:605077) May Have Issues Allocating Its Capital

May 28
Zhejiang Huakang Pharmaceutical (SHSE:605077) May Have Issues Allocating Its Capital

We Think That There Are Some Issues For Zhejiang Huakang Pharmaceutical (SHSE:605077) Beyond Its Promising Earnings

May 02
We Think That There Are Some Issues For Zhejiang Huakang Pharmaceutical (SHSE:605077) Beyond Its Promising Earnings

CEO

Deshui Chen (55 yo)

no data

Tenure

CN¥1,505,800

Compensatie

Mr. Deshui Chen is Non-Executive Director of Zhejiang Kaihua Rural Commercial Bank Company Limited. He is Chairman of the Board & GM of Zhejiang Huakang Pharmaceutical Co. Ltd.